The Future Is Now: Decentralized Clinical Trials During the Pandemic and Beyond

July 22, 2020

Decentralized clinical trials (DCT) had already begun to gain momentum, and the pandemic has dramatically accelerated their adoption. Enabling patients to participate in clinic trials from home is both incredibly important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for a second wave of COVID-19.

Previous Article
Has EMA started a domino effect for more regulation of API manufacturing?
Has EMA started a domino effect for more regulation of API manufacturing?

On June 23, 2020 the European Medicines Agency (EMA) released a report on lessons learned from the presence...

Next Article
Case Study: Parexel® Medical Imaging Supports AbbVie’s Elagolix

Recently, Parexel supported a Phase III study of AbbVie’s Elagolix, a uterine fibroid treatment, that incor...